Cargando…
Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease
BACKGROUND: Biomarker identification is becoming increasingly important for the development of personalized or stratified therapies. Metabolomics yields biomarkers indicative of phenotype that can be used to characterize transitions between health and disease, disease progression and therapeutic res...
Autores principales: | Lodi, Alessia, Tiziani, Stefano, Khanim, Farhat L., Günther, Ulrich L., Viant, Mark R., Morgan, Gareth J., Bunce, Christopher M., Drayson, Mark T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576408/ https://www.ncbi.nlm.nih.gov/pubmed/23431376 http://dx.doi.org/10.1371/journal.pone.0056422 |
Ejemplares similares
-
Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation
por: Lodi, Alessia, et al.
Publicado: (2010) -
Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
por: Tiziani, Stefano, et al.
Publicado: (2009) -
Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
por: Tiziani, Stefano, et al.
Publicado: (2009) -
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies
por: Bunce, Chris M., et al.
Publicado: (2022) -
Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)